nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—Hypersensitivity—Ifosfamide—testicular cancer	0.00146	0.00146	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00145	0.00145	CcSEcCtD
Tadalafil—Renal failure—Methotrexate—testicular cancer	0.00144	0.00144	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Tadalafil—Conjunctivitis—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Tadalafil—Dysphagia—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Tadalafil—Influenza—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Tadalafil—Asthenia—Ifosfamide—testicular cancer	0.00142	0.00142	CcSEcCtD
Tadalafil—Sweating—Methotrexate—testicular cancer	0.00141	0.00141	CcSEcCtD
Tadalafil—Paraesthesia—Etoposide—testicular cancer	0.0014	0.0014	CcSEcCtD
Tadalafil—Pruritus—Ifosfamide—testicular cancer	0.0014	0.0014	CcSEcCtD
Tadalafil—Haematuria—Methotrexate—testicular cancer	0.0014	0.0014	CcSEcCtD
Tadalafil—Dyspnoea—Etoposide—testicular cancer	0.00139	0.00139	CcSEcCtD
Tadalafil—Somnolence—Etoposide—testicular cancer	0.00139	0.00139	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Tadalafil—Epistaxis—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Tadalafil—Nausea—Bleomycin—testicular cancer	0.00138	0.00138	CcSEcCtD
Tadalafil—Infestation NOS—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Tadalafil—Infestation—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Tadalafil—Vomiting—Dactinomycin—testicular cancer	0.00137	0.00137	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Tadalafil—Rash—Dactinomycin—testicular cancer	0.00136	0.00136	CcSEcCtD
Tadalafil—Diarrhoea—Ifosfamide—testicular cancer	0.00135	0.00135	CcSEcCtD
Tadalafil—Renal failure—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Tadalafil—Fatigue—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Tadalafil—Pain—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Tadalafil—Constipation—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Tadalafil—Urinary tract infection—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Tadalafil—Conjunctivitis—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Tadalafil—Haemoglobin—Methotrexate—testicular cancer	0.00132	0.00132	CcSEcCtD
Tadalafil—Haemorrhage—Methotrexate—testicular cancer	0.00132	0.00132	CcSEcCtD
Tadalafil—Sweating—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Tadalafil—Haematuria—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Tadalafil—Dizziness—Ifosfamide—testicular cancer	0.00131	0.00131	CcSEcCtD
Tadalafil—Pharyngitis—Methotrexate—testicular cancer	0.00131	0.00131	CcSEcCtD
Tadalafil—Urinary tract disorder—Methotrexate—testicular cancer	0.0013	0.0013	CcSEcCtD
Tadalafil—Epistaxis—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Tadalafil—Urethral disorder—Methotrexate—testicular cancer	0.00129	0.00129	CcSEcCtD
Tadalafil—Nausea—Dactinomycin—testicular cancer	0.00128	0.00128	CcSEcCtD
Tadalafil—Gastrointestinal pain—Etoposide—testicular cancer	0.00128	0.00128	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Tadalafil—Vomiting—Ifosfamide—testicular cancer	0.00126	0.00126	CcSEcCtD
Tadalafil—Hypersensitivity—Cisplatin—testicular cancer	0.00126	0.00126	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Tadalafil—Rash—Ifosfamide—testicular cancer	0.00125	0.00125	CcSEcCtD
Tadalafil—Dermatitis—Ifosfamide—testicular cancer	0.00125	0.00125	CcSEcCtD
Tadalafil—Erythema multiforme—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Tadalafil—Urticaria—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Tadalafil—Abdominal pain—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Tadalafil—Eye disorder—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Tadalafil—Tinnitus—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Tadalafil—Hypoaesthesia—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Tadalafil—Asthenia—Cisplatin—testicular cancer	0.00122	0.00122	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Tadalafil—Cardiac disorder—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Tadalafil—Haematuria—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Tadalafil—Urethral disorder—Epirubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Tadalafil—Epistaxis—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Tadalafil—Angiopathy—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Tadalafil—Immune system disorder—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Tadalafil—Mediastinal disorder—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Tadalafil—Nausea—Ifosfamide—testicular cancer	0.00118	0.00118	CcSEcCtD
Tadalafil—Diarrhoea—Cisplatin—testicular cancer	0.00117	0.00117	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Tadalafil—Mental disorder—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Tadalafil—Hypersensitivity—Etoposide—testicular cancer	0.00115	0.00115	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Tadalafil—Cardiac disorder—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Tadalafil—Flushing—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Tadalafil—Asthenia—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Tadalafil—Back pain—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Tadalafil—Pruritus—Etoposide—testicular cancer	0.00111	0.00111	CcSEcCtD
Tadalafil—Vomiting—Cisplatin—testicular cancer	0.00108	0.00108	CcSEcCtD
Tadalafil—Vision blurred—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Tadalafil—Rash—Cisplatin—testicular cancer	0.00108	0.00108	CcSEcCtD
Tadalafil—Dermatitis—Cisplatin—testicular cancer	0.00107	0.00107	CcSEcCtD
Tadalafil—Diarrhoea—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Tadalafil—Back pain—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Dizziness—Etoposide—testicular cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Vertigo—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Nausea—Cisplatin—testicular cancer	0.00101	0.00101	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Tadalafil—Cough—Methotrexate—testicular cancer	0.001	0.001	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—testicular cancer	0.000999	0.000999	CcSEcCtD
Tadalafil—Convulsion—Methotrexate—testicular cancer	0.000994	0.000994	CcSEcCtD
Tadalafil—Vomiting—Etoposide—testicular cancer	0.000993	0.000993	CcSEcCtD
Tadalafil—Rash—Etoposide—testicular cancer	0.000985	0.000985	CcSEcCtD
Tadalafil—Dermatitis—Etoposide—testicular cancer	0.000984	0.000984	CcSEcCtD
Tadalafil—Headache—Etoposide—testicular cancer	0.000979	0.000979	CcSEcCtD
Tadalafil—Myalgia—Methotrexate—testicular cancer	0.000976	0.000976	CcSEcCtD
Tadalafil—Arthralgia—Methotrexate—testicular cancer	0.000976	0.000976	CcSEcCtD
Tadalafil—Chest pain—Methotrexate—testicular cancer	0.000976	0.000976	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00097	0.00097	CcSEcCtD
Tadalafil—Discomfort—Methotrexate—testicular cancer	0.000965	0.000965	CcSEcCtD
Tadalafil—Vertigo—Epirubicin—testicular cancer	0.000964	0.000964	CcSEcCtD
Tadalafil—Syncope—Epirubicin—testicular cancer	0.000962	0.000962	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—testicular cancer	0.000961	0.000961	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—testicular cancer	0.000955	0.000955	CcSEcCtD
Tadalafil—Palpitations—Epirubicin—testicular cancer	0.000948	0.000948	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—testicular cancer	0.000943	0.000943	CcSEcCtD
Tadalafil—Cough—Epirubicin—testicular cancer	0.000937	0.000937	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—testicular cancer	0.000936	0.000936	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—testicular cancer	0.00093	0.00093	CcSEcCtD
Tadalafil—Infection—Methotrexate—testicular cancer	0.00093	0.00093	CcSEcCtD
Tadalafil—Nausea—Etoposide—testicular cancer	0.000928	0.000928	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—testicular cancer	0.000927	0.000927	CcSEcCtD
Tadalafil—Nervous system disorder—Methotrexate—testicular cancer	0.000918	0.000918	CcSEcCtD
Tadalafil—Myalgia—Epirubicin—testicular cancer	0.000914	0.000914	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—testicular cancer	0.000914	0.000914	CcSEcCtD
Tadalafil—Arthralgia—Epirubicin—testicular cancer	0.000914	0.000914	CcSEcCtD
Tadalafil—Skin disorder—Methotrexate—testicular cancer	0.000909	0.000909	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000907	0.000907	CcSEcCtD
Tadalafil—Hyperhidrosis—Methotrexate—testicular cancer	0.000905	0.000905	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—testicular cancer	0.000903	0.000903	CcSEcCtD
Tadalafil—Dry mouth—Epirubicin—testicular cancer	0.000894	0.000894	CcSEcCtD
Tadalafil—Vertigo—Doxorubicin—testicular cancer	0.000892	0.000892	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—testicular cancer	0.000891	0.000891	CcSEcCtD
Tadalafil—Palpitations—Doxorubicin—testicular cancer	0.000878	0.000878	CcSEcCtD
Tadalafil—Oedema—Epirubicin—testicular cancer	0.000876	0.000876	CcSEcCtD
Tadalafil—Hypotension—Methotrexate—testicular cancer	0.000875	0.000875	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—testicular cancer	0.000873	0.000873	CcSEcCtD
Tadalafil—Infection—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Tadalafil—Cough—Doxorubicin—testicular cancer	0.000867	0.000867	CcSEcCtD
Tadalafil—Shock—Epirubicin—testicular cancer	0.000862	0.000862	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—testicular cancer	0.00086	0.00086	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—testicular cancer	0.000859	0.000859	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—testicular cancer	0.000857	0.000857	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—testicular cancer	0.000855	0.000855	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000853	0.000853	CcSEcCtD
Tadalafil—Skin disorder—Epirubicin—testicular cancer	0.000851	0.000851	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—testicular cancer	0.000847	0.000847	CcSEcCtD
Tadalafil—Insomnia—Methotrexate—testicular cancer	0.000847	0.000847	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Tadalafil—Paraesthesia—Methotrexate—testicular cancer	0.00084	0.00084	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00084	0.00084	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—testicular cancer	0.000835	0.000835	CcSEcCtD
Tadalafil—Dyspnoea—Methotrexate—testicular cancer	0.000834	0.000834	CcSEcCtD
Tadalafil—Somnolence—Methotrexate—testicular cancer	0.000832	0.000832	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—testicular cancer	0.000827	0.000827	CcSEcCtD
Tadalafil—Dyspepsia—Methotrexate—testicular cancer	0.000824	0.000824	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Tadalafil—Oedema—Doxorubicin—testicular cancer	0.00081	0.00081	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000808	0.000808	CcSEcCtD
Tadalafil—Fatigue—Methotrexate—testicular cancer	0.000807	0.000807	CcSEcCtD
Tadalafil—Infection—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Tadalafil—Pain—Methotrexate—testicular cancer	0.0008	0.0008	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000798	0.000798	CcSEcCtD
Tadalafil—Shock—Doxorubicin—testicular cancer	0.000797	0.000797	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—testicular cancer	0.000795	0.000795	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—testicular cancer	0.000792	0.000792	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—testicular cancer	0.000791	0.000791	CcSEcCtD
Tadalafil—Skin disorder—Doxorubicin—testicular cancer	0.000787	0.000787	CcSEcCtD
Tadalafil—Paraesthesia—Epirubicin—testicular cancer	0.000786	0.000786	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—testicular cancer	0.000783	0.000783	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—testicular cancer	0.000781	0.000781	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—testicular cancer	0.000779	0.000779	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—testicular cancer	0.000771	0.000771	CcSEcCtD
Tadalafil—Gastrointestinal pain—Methotrexate—testicular cancer	0.000765	0.000765	CcSEcCtD
Tadalafil—Hypotension—Doxorubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000756	0.000756	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—testicular cancer	0.000755	0.000755	CcSEcCtD
Tadalafil—Constipation—Epirubicin—testicular cancer	0.000749	0.000749	CcSEcCtD
Tadalafil—Pain—Epirubicin—testicular cancer	0.000749	0.000749	CcSEcCtD
Tadalafil—Urticaria—Methotrexate—testicular cancer	0.000744	0.000744	CcSEcCtD
Tadalafil—Abdominal pain—Methotrexate—testicular cancer	0.00074	0.00074	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Tadalafil—Insomnia—Doxorubicin—testicular cancer	0.000733	0.000733	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—testicular cancer	0.000728	0.000728	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—testicular cancer	0.000723	0.000723	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—testicular cancer	0.000716	0.000716	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—testicular cancer	0.000713	0.000713	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.0007	0.0007	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—testicular cancer	0.000696	0.000696	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—testicular cancer	0.000693	0.000693	CcSEcCtD
Tadalafil—Pain—Doxorubicin—testicular cancer	0.000693	0.000693	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Tadalafil—Hypersensitivity—Methotrexate—testicular cancer	0.00069	0.00069	CcSEcCtD
Tadalafil—Asthenia—Methotrexate—testicular cancer	0.000672	0.000672	CcSEcCtD
Tadalafil—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Tadalafil—Pruritus—Methotrexate—testicular cancer	0.000662	0.000662	CcSEcCtD
Tadalafil—Hypersensitivity—Epirubicin—testicular cancer	0.000645	0.000645	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—testicular cancer	0.000644	0.000644	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—testicular cancer	0.000641	0.000641	CcSEcCtD
Tadalafil—Diarrhoea—Methotrexate—testicular cancer	0.00064	0.00064	CcSEcCtD
Tadalafil—Asthenia—Epirubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Tadalafil—Pruritus—Epirubicin—testicular cancer	0.00062	0.00062	CcSEcCtD
Tadalafil—Dizziness—Methotrexate—testicular cancer	0.000619	0.000619	CcSEcCtD
Tadalafil—Diarrhoea—Epirubicin—testicular cancer	0.000599	0.000599	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Tadalafil—Vomiting—Methotrexate—testicular cancer	0.000595	0.000595	CcSEcCtD
Tadalafil—Rash—Methotrexate—testicular cancer	0.00059	0.00059	CcSEcCtD
Tadalafil—Dermatitis—Methotrexate—testicular cancer	0.00059	0.00059	CcSEcCtD
Tadalafil—Headache—Methotrexate—testicular cancer	0.000586	0.000586	CcSEcCtD
Tadalafil—Asthenia—Doxorubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—testicular cancer	0.000579	0.000579	CcSEcCtD
Tadalafil—Pruritus—Doxorubicin—testicular cancer	0.000573	0.000573	CcSEcCtD
Tadalafil—Vomiting—Epirubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Tadalafil—Nausea—Methotrexate—testicular cancer	0.000556	0.000556	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—testicular cancer	0.000555	0.000555	CcSEcCtD
Tadalafil—Rash—Epirubicin—testicular cancer	0.000552	0.000552	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—testicular cancer	0.000552	0.000552	CcSEcCtD
Tadalafil—Headache—Epirubicin—testicular cancer	0.000549	0.000549	CcSEcCtD
Tadalafil—Dizziness—Doxorubicin—testicular cancer	0.000536	0.000536	CcSEcCtD
Tadalafil—Nausea—Epirubicin—testicular cancer	0.00052	0.00052	CcSEcCtD
Tadalafil—Vomiting—Doxorubicin—testicular cancer	0.000515	0.000515	CcSEcCtD
Tadalafil—Rash—Doxorubicin—testicular cancer	0.000511	0.000511	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—testicular cancer	0.000511	0.000511	CcSEcCtD
Tadalafil—Headache—Doxorubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Tadalafil—Nausea—Doxorubicin—testicular cancer	0.000481	0.000481	CcSEcCtD
